Quick Takeaways
- KKR Genetic Disorder L.P. filed SCHEDULE 13D/A for BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share (BBIO).
- Disclosed ownership: 7%.
- Date of event: 12 May 2025.
KKR Genetic Disorder L.P. - 12 May 2025 SCHEDULE 13D/A Report for BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share (BBIO)
- Filing Manager
- KKR Genetic Disorder L.P.
- Reporting Manager
- KKR Genetic Disorder L.P.
- Symbol
- BBIO
- Shares outstanding
- 189,442,443 shares
- Disclosed Ownership
- 13,260,971 shares
- Ownership
- 7%
- Form type
- SCHEDULE 13D/A
- Filing time
- 14 May 2025, 17:52:58 UTC
- Date of event
- 12 May 2025
- Previous filing
- 07 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"KKR Genetic Disorder L.P. disclosed 7% ownership in BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share (BBIO) on 12 May 2025."
What Changed
- Previous schedule filing date: 07 Mar 2025.
- Current filing was accepted on 14 May 2025, 17:52.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (9)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| KKR Genetic Disorder L.P. | 7% | 13,260,971 | 13,260,971 | 0 | /s/ Christopher Lee | Christopher Lee, Assistant Secretary, KKR Genetic Disorder GP LLC, its general partner | 0001780408 |
| KKR Genetic Disorder GP LLC | 7% | 13,260,971 | 13,260,971 | 0 | /s/ Christopher Lee | Christopher Lee, Assistant Secretary | |
| KKR Group Partnership L.P. | 7% | 13,260,971 | 13,260,971 | 0 | /s/ Christopher Lee | Christopher Lee, Secretary, KKR Group Holdings Corp., its general partner | |
| KKR Group Holdings Corp. | 7% | 13,260,971 | 13,260,971 | 0 | /s/ Christopher Lee | Christopher Lee, Secretary | |
| KKR Group Co. Inc. | 7% | 13,260,971 | 13,260,971 | 0 | /s/ Christopher Lee | Christopher Lee, Secretary | |
| KKR & Co. Inc. | 7% | 13,260,971 | 13,260,971 | 0 | /s/ Christopher Lee | Christopher Lee, Secretary | |
| KKR Management LLP | 7% | 13,260,971 | 13,260,971 | 0 | /s/ Christopher Lee | Christopher Lee, Assistant Secretary | |
| Henry R. Kravis | 7% | 13,260,971 | 0 | 13,260,971 | /s/ Christopher Lee | Christopher Lee, Attorney-in-fact | |
| George R. Roberts | 7% | 13,260,971 | 0 | 13,260,971 | /s/ Christopher Lee | Christopher Lee, Attorney-in-fact |